杭州易文赛生物技术

Hangzhou Yiwen Cell Biotechnology is a leading Chinese biotechnology company focused on the development and clinical application of stem cell therapies. Established in 2009, the company operates a large-scale cell bank and a GMP-compliant manufacturing facility in Hangzhou. Their core research centers on umbilical cord-derived mesenchymal stem cells (UC-MSCs) for treating a variety of conditions, including liver diseases and orthopedic disorders. Yiwen Cell has successfully advanced several programs into Phase 2 clinical trials and maintains collaborations with top-tier academic and medical institutions in China. The company also provides cell storage services and is recognized as a key player in the regional regenerative medicine sector.